Journal
MULTIPLE SCLEROSIS JOURNAL
Volume 26, Issue 6, Pages 737-740Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/1352458520913277
Keywords
Multiple sclerosis; alemtuzumab; adverse events